FutureChem Co

FutureChem Co ROA

The Return on Assets (ROA) of FutureChem Co (220100.KQ) as of Oct 21, 2026 is -15.10 %. In the previous year, Return on Assets (ROA) was -12.65 % — a change of 19.30% (lower).

ROA

-15.10 %

YoY

19.30%

Last updated:

In 2025, FutureChem Co's return on assets (ROA) was -15.10 %, a 19.30% increase from the -12.65 % ROA in the previous year.

The FutureChem Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-18.69 KRW
Jan 1, 2019
-8.49 KRW
Jan 1, 2020
-28.02 KRW
Jan 1, 2021
-4.43 KRW
Jan 1, 2022
-15.73 KRW
Jan 1, 2023
-9.21 KRW
Jan 1, 2024
-12.65 KRW
Jan 1, 2025
-15.10 KRW
The FutureChem Co ROA history
YEARROAYoY
-15.10 %+19.30%
-12.65 %+37.38%
-9.21 %-41.46%
-15.73 %+254.93%
-4.43 %-84.18%
-28.02 %+229.92%
-8.49 %-54.56%
-18.69 %+49.81%
-12.47 %-84.86%
-82.42 %+149.33%
-33.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FutureChem Co Stock analysis

What does FutureChem Co do? FutureChem Co., Ltd. generates revenue through the manufacture and distribution of radiopharmaceuticals, including diagnostic agents for lung cancer, Parkinson's disease, and Alzheimer's disease. The company produces medical automation modules such as cubes, disposable cassettes, reagent kits, radio-caps, and kryptofix kits, alongside PET and SPECT precursors for radiopharmaceuticals. These products are sold to healthcare providers, diagnostic centers, and medical facilities requiring specialized radiopharmaceutical solutions. The firm also develops metal chelating agents and fluorescence probes for medical applications. The primary buyers of FutureChem's products include hospitals, clinics, and research institutions focused on cancer diagnostics and neurological conditions. Medical automation modules and disposable goods are utilized in diagnostic procedures, while PET and SPECT precursors support imaging technologies. Metal chelating agents and fluorescence probes are integrated into medical testing and imaging processes. FutureChem's revenue streams are driven by the demand for advanced diagnostic tools in oncology and neurology. The company's portfolio targets healthcare segments requiring early detection of diseases, with products designed for both diagnostic imaging and laboratory testing. Sales are concentrated in medical facilities that prioritize precision diagnostics and specialized treatment planning. FutureChem Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding FutureChem Co's Return on Assets (ROA)

FutureChem Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing FutureChem Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider FutureChem Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in FutureChem Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about FutureChem Co stock

Return on Assets (ROA) of FutureChem Co is -15.10 % in 2025.

Return on Assets (ROA) of FutureChem Co changed from -12.65 % to -15.10 %, representing a 19.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) FutureChem Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s FutureChem Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — FutureChem Co

All Key Metrics — FutureChem Co